20 December 2023

2023 has been a significant year for the global lung cancer community. More and more, low-dose computed tomography (LDCT) screening for lung cancer is being used to facilitate the early detection of lung cancer across the globe. Governments are enshrining lung cancer prevention, screening and detection into their health services. England has committed to the full implementation of its targeted lung health check programme, while Australia has committed over AUS $500 million to the prevention and screening of lung cancer.

Vast swathes of research have been published to bolster the evidence base for the earlier detection of lung cancer. Notably, the twenty-year follow-up results from the International Early Lung Cancer Action Program (I-ELCAP) study have demonstrated that LDCT screening for lung cancer improves diagnosis rates and reduces mortality.

As a Network, we have expanded our membership and activities, while also broadening our remit to include the optimisation of care pathways and wider opportunities to enhance earlier detection. Additionally, we have worked to develop further tools that support the implementation of LDCT screening.

This year, the Network has focused on building an extensive evidence base that underpins key policy goals which look at addressing the global burden of lung cancer. We have published:

This year, the Network has grown significantly, now with over 70 members, representing 24 countries and 16 organisations. The Network has presented outputs at 6 international conferences, and hosted a webinar on the implementation of lung cancer screening that drew an audience from over 30 countries.

As we look ahead to 2024, we want to focus next on driving policy action. Through our work next year, we aim to ensure that the evidence base and policy recommendations curated by the Network in 2023are effectively disseminated to policymakers and lung cancer advocates. As part of this, we plan to continue growing Network membership and fostering collaborations with organisations to further advance our mission.

In January 2024, we will be publishing the Network 2023 in review report which summarises the impact the Network has had this past year, and features insights from members sharing their perspectives on the Network’s role within the wider policy landscape.



Recent news


Network publishes year in review report to demonstrate annual achievements

Network publishes year in review report to demonstrate annual achievements

The Lung Cancer Policy Network has published its 2023 in review: building the evidence base report, detailing what the Network and its members have achieved over the past year.


Meet our members: Ebba Hallersjö Hult

Meet our members: Ebba Hallersjö Hult

We speak to Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer, a mission-oriented innovation hub coordinated by Stockholm School of Economics Institute for Research, Sweden.

Case study

Lung cancer screening in Croatia: leading the way for earlier detection in Europe

Lung cancer screening in Croatia: leading the way for earlier detection in Europe

We explore key considerations for the success of the lung cancer screening programme in Croatia, discussing the pivotal role that integrated technology and reimbursement for primary care providers have played.